克林霉素磷酸酯治疗呼吸系统感染的临床分析

摘要

Objective To explore the clinical ef ect of clindamycin phosphatein the treatment of respiratory system infection, to guide the clinical treatment. Methods Patients with respiratory system diseases were treatedin our hospital in 2010 were selected between January to 2012 January 84 cases of infection were studied, in accordance with the principle of randomization is divided into the observation group and the control group with 42 cases in each. The observation group was treated with clindamycin phosphate treatment, control group used levofloxacin for treatment, wereobserved and analyzed on two groups of curative ef ect and adverse reaction. Results The patients in the observation group the total ef ective rate was 97.6%, the incidence rate of adverse reaction was 7.1%; the control group the total ef ective rate was 85.7%, the incidence rate of adverse reaction was 24%, the two group total ef iciency and adverse reaction rate comparison with significant dif erences in treatment, comparedwith statistical significance < 0.05. Conclusion The treatment of respiratory system infection of clindamycin phosphate, clinical ef ect than the conventional levofloxacin hydrochloride treatment is more obvious, less adverse reaction, ef ectively promote the rehabilitation of patients.%目的探讨克林霉素磷酸酯治疗呼吸系统感染的临床效果，进一步指导临床治疗。方法选取我院2010年1月~2012年1月收治的呼吸系统感染疾病患者84例进行研究，按照随机分组原则划分为观察组和对照组各42例。观察组采用克林霉素磷酸酯进行治疗，对照组采用盐酸左氧氟沙星进行治疗，对两组的治疗效果和不良反应进行观察和对比分析。结果观察组患者治疗总有效率为97.6%，不良反应发生率为7.1%；对照组治疗总有效率为85.7%，不良反应发生率为24%，两组在治疗总有效率和不良反应发生率方面的对比具有显著差异，对比具有统计学意义P<0.05。结论采用克林霉素磷酸酯治疗呼吸系统感染，较常规盐酸左氧氟沙星治疗的临床效果更为显著，不良反应少，有效促进了患者的康复。